Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo and Proskauer Rose advised Sixth Street. Arrowhead...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Arrowhead Pharmaceuticals, Inc. on the offering. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced the pricing of an underwritten registered offering...
You must be a Standard 1 Year member to access this content.
